- Home
- TK vs PHAR Comparison
TK vs PHAR Comparison
Compare TK & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TK
- PHAR
- Stock Information
- Founded
- TK 1973
- PHAR 1988
- Country
- TK Bermuda
- PHAR Netherlands
- Employees
- TK N/A
- PHAR N/A
- Industry
- TK Marine Transportation
- PHAR Biotechnology: Pharmaceutical Preparations
- Sector
- TK Consumer Discretionary
- PHAR Health Care
- Exchange
- TK Nasdaq
- PHAR Nasdaq
- Market Cap
- TK 701.1M
- PHAR 707.9M
- IPO Year
- TK 1995
- PHAR N/A
- Fundamental
- Price
- TK $7.67
- PHAR $10.09
- Analyst Decision
- TK
- PHAR Strong Buy
- Analyst Count
- TK 0
- PHAR 3
- Target Price
- TK N/A
- PHAR $30.00
- AVG Volume (30 Days)
- TK 698.1K
- PHAR 3.7K
- Earning Date
- TK 07-30-2025
- PHAR 07-31-2025
- Dividend Yield
- TK 26.39%
- PHAR N/A
- EPS Growth
- TK 13.88
- PHAR N/A
- EPS
- TK 1.85
- PHAR N/A
- Revenue
- TK $1,086,963,000.00
- PHAR $320,708,000.00
- Revenue This Year
- TK N/A
- PHAR $13.31
- Revenue Next Year
- TK N/A
- PHAR $7.68
- P/E Ratio
- TK $4.19
- PHAR N/A
- Revenue Growth
- TK N/A
- PHAR 24.13
- 52 Week Low
- TK $5.65
- PHAR $6.73
- 52 Week High
- TK $9.78
- PHAR $12.61
- Technical
- Relative Strength Index (RSI)
- TK 45.09
- PHAR 47.03
- Support Level
- TK $7.51
- PHAR $9.80
- Resistance Level
- TK $7.75
- PHAR $10.46
- Average True Range (ATR)
- TK 0.18
- PHAR 0.28
- MACD
- TK 0.03
- PHAR -0.01
- Stochastic Oscillator
- TK 60.87
- PHAR 39.94
About TK Teekay Corporation
Teekay Corp Ltd provides international crude oil marine transportation and other marine services. It also offers offshore oil production, storage, and offloading services, under long-term, fixed-rate contracts. The company has two primary lines of business: Marine services and tankers. It manages these businesses for the benefit of all stakeholders. The company serves energy and utility companies, oil traders, large oil and LNG consumers, petroleum product producers, government agencies, and various other entities that depend upon marine transportation.
About PHAR Pharming Group N.V.
Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.